Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by patience69on May 05, 2018 2:32pm

180 Views

Post# 27987449

share price discussion

Just open discussion right. I hate to sound greedy but $3. I know its crazy with the current share price but 3 Canadian is really not much. That would be less than 300M US $ market cap. That seems too cheap if we have 4 or 5 cancer free at 90 days & maybe even several at 180 days either cancer free or no progression. Once phase 2 has begun with those kind of results IMO we should be worth more???

Bullboard Posts

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal